报价延迟最少15分钟:2025/09/05 18:01 EDT
盘后时段
|
||||
|
5.18 
|
|
|
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-3.63/-1.90
|
|
企业价值
67.23M
|
| 资产负债 |
|
每股账面净值
-0.57
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
326.00K
|
|
每股收益
0.04
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
报价延迟最少15分钟：2025/09/05 18:01 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech. |
